You can email us at, or call us on 01202 539791.Email: Phone: 01202 539791.



Bortezomib,a proteasome inhibitor, is licensed as monotherapy, or in combination with pegylated liposomal doxorubicin or dexamethasone, for the treatment of multiple myeloma that has progressed despite the use of at least one therapy

Product Details

Category Cancer Research and Antivirals
Price POA
CAS Number 179324-69-7
Formula C19H25BN4O4
Molecular Weight 384.24
Purity 99%
Appearance white solid
Availability In Stock
Storage Conditions -18°C

Product Enquiry

Send us your enquiry for Bortezomib. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.

We value your input so if you have suggestions regarding new applications for Bortezomib email us and we will include your contribution on the website.

Enquire about product

Back to Top